![Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors](/docs/US/2020-09-29/US10787438B2/abs.jpg.600x600.jpg)
- Patent Title: Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors
-
Application No.: US16744283Application Date: 2020-01-16
-
Publication No.: US10787438B2Publication Date: 2020-09-29
- Inventor: Matthew Dowling , Dilinie Fernando , Kentaro Futatsugi , Kim Huard , Thomas Victor Magee , Brian Raymer , Andre Shavnya , Aaron Smith , Benjamin Thuma , Andy Tsai , Meihua Tu
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent Richard V. Zanzalari
- Main IPC: C07D403/14
- IPC: C07D403/14 ; A61K31/403 ; C07D401/04 ; C07D401/14 ; C07D403/04
![Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors](/abs-image/US/2020/09/29/US10787438B2/abs.jpg.150x150.jpg)
Abstract:
Provided herein are substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors, processes to make said compounds, and methods comprising administering said compounds to a mammal in need thereof.
Public/Granted literature
- US20200148669A1 SUBSTITUTED 3-AZABICYCLO[3.1.0]HEXANES AS KETOHEXOKINASE INHIBITORS Public/Granted day:2020-05-14
Information query
